14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OGXI
Delisted

OncoGenex Pharmaceuticals Inc. Fund Signals

$0.400
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 40 days ( 0 % )
Last Price $0.400 0 %
High/ Low $0.400 - $0.400 0%
Chg 7 Days N/A $0.400 $0.400
Chg 30 Days N/A $0.400 $0.400
Chg 12 mos -33.33 % $0.600 $0.400
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -26.71 % Width: 97.25 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $0.178 - $0.351 -55.53 % - -12.29 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Aug 17, 2017 - 41 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Jan 15, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About OncoGenex Pharmaceuticals Inc.

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company’s product candidates include Custirsen that is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate cancer, as well as in patients with non-small cell lung cancer; and Apatorsen, which is in two Phase I and seven randomized Phase II ... OGXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT